As of Sept. 14 10:25 A.M., Ilyang Pharmaceutical declined 2.06%, compared with yesterday, to 33,350 won. It had declined 3.47% through the past month. Standard deviation, which indicates variableness, records 1.5% over the same period of time over one month.
Compared with its close competitors within the same industry, KOSPI, since the monthly volatility of Ilyang Pharmaceutical was at a low level, the earnings rate over one month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -2.3%.
The return-on-risk is below the industrial mean, 1.2, and thus the industrial comparison performance was not so good.
By HeRo (firstname.lastname@example.org
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.